Cellogen Therapeutics
“Cellogen Therapeutics” is biotech startup which is striving today to come up with innovative cell therapy-based solutions for a healthy tomorrow.
“Cellogen Therapeutics” is biotech startup which is striving today to come up with innovative cell therapy-based solutions for a healthy tomorrow.
We at Cellogen Therapeutics use advanced cellular engineering methods and gene therapy-based approaches to cure various hematological malignancies, solid tumors, hemoglobinopathies and other inherited and metabolic disorders.
CAR-T cell therapy is a cell-based immunotherapy approach in which patients' own immune cells are activated ex-vivo to fight against the disease. Recent advancement in the field has led to the approval of ten CAR-T cell-based therapies against hematological malignancies by the USA Food and Drug Administration. As of now there are no approved CAR-T based therapies for solid tumors, but the same approach can be adopted by using an innovative solution.